{"result": "{\n    \"title\": \"Cystic Fibrosis and Nutritional Management in Spain\",\n    \"summary\": \"The community focuses on the management of Cystic Fibrosis (Fibrosis Quística) and its associated nutritional challenges in Spain. Key entities include various health conditions related to Cystic Fibrosis, nutritional interventions, and the role of Spain's healthcare system in addressing these needs.\",\n    \"rating\": 7.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the significant health challenges posed by Cystic Fibrosis and the critical need for effective nutritional management.\",\n    \"findings\": [\n        {\n            \"summary\": \"Cystic Fibrosis as a complex genetic disorder\",\n            \"explanation\": \"Cystic Fibrosis, or Fibrosis Quística, is a genetic disorder that primarily affects the lungs and digestive system, leading to severe respiratory issues and nutritional challenges. Patients often require specific dietary interventions and enzyme supplementation to manage their condition effectively. The complexity of this disorder necessitates ongoing care and support to mitigate its impact on health and quality of life [Data: Entities (919); Relationships (2525, 745)].\"\n        },\n        {\n            \"summary\": \"Nutritional challenges associated with Cystic Fibrosis\",\n            \"explanation\": \"Individuals with Cystic Fibrosis face significant nutritional challenges due to malabsorption issues, which can lead to malnutrition and related health complications. Nutritional support, including enteral nutrition and pancreatic enzyme supplementation, is essential for these patients to ensure adequate nutrient intake and improve their overall health outcomes [Data: Entities (919, 1780, 1784); Relationships (90, 91, 2550)].\"\n        },\n        {\n            \"summary\": \"The role of Spain in Cystic Fibrosis research\",\n            \"explanation\": \"Spain is actively involved in research related to Cystic Fibrosis, focusing on nutritional support and treatment strategies. The country has organized research groups dedicated to studying the condition, which contributes to the development of guidelines and recommendations for managing Cystic Fibrosis effectively [Data: Entities (713); Relationships (837, 2198)].\"\n        },\n        {\n            \"summary\": \"Pancreatic enzyme preparations as critical interventions\",\n            \"explanation\": \"Pancreatic enzyme preparations, such as Kreon 10000, Kreon 25000, and Kreon 5000 granulado, are crucial for patients with Cystic Fibrosis who experience exocrine pancreatic insufficiency. These supplements aid in digestion and nutrient absorption, significantly improving the quality of life for affected individuals [Data: Entities (1784, 1785, 1786); Relationships (2540, 2541, 2549)].\"\n        },\n        {\n            \"summary\": \"Associated health conditions complicating Cystic Fibrosis\",\n            \"explanation\": \"Cystic Fibrosis is often associated with other health conditions, such as portal hypertension, osteopenia, and gastroesophageal reflux disease (GERD). These comorbidities can complicate the management of Cystic Fibrosis and require integrated care approaches to address the multifaceted health needs of patients [Data: Entities (1689, 1754, 1691); Relationships (636, 3612, 2523)].\"\n        },\n        {\n            \"summary\": \"Nutritional interventions tailored for children\",\n            \"explanation\": \"Children with Cystic Fibrosis have specific dietary needs that differ from adults, including the necessity for sodium supplementation and tailored nutritional interventions. Addressing these unique requirements is vital for their growth and development, as well as for managing their condition effectively [Data: Entities (919); Relationships (2537)].\"\n        },\n        {\n            \"summary\": \"The importance of monitoring and research in Spain\",\n            \"explanation\": \"Ongoing monitoring and research in Spain regarding Cystic Fibrosis and its nutritional management are essential for improving patient outcomes. Studies conducted in the country help to inform best practices and ensure that patients receive the most effective care possible [Data: Entities (713); Relationships (2196, 2202)].\"\n        }\n    ]\n}", "input": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\r\n919,FIBROSIS QUÍSTICA,\"Fibrosis Quística, also known as Cystic Fibrosis, is a genetic disorder that primarily affects the lungs and digestive system. This condition is characterized by the production of thick mucus, which can lead to severe respiratory issues and complications, including frequent lung infections. Additionally, it poses significant nutritional challenges, often resulting in malnutrition due to difficulties in digestion and absorption of nutrients.\n\nIndividuals with Fibrosis Quística require specific nutritional support and enzyme supplementation to aid in proper digestion. The management of this disorder involves a comprehensive approach that includes dietary adjustments and medical interventions to address both respiratory and nutritional needs. Overall, Fibrosis Quística is a complex genetic condition that necessitates ongoing care and support to mitigate its impact on health and quality of life.\",44\r\n1689,HIPERTENSIÓN PORTAL,\"Portal hypertension is a serious complication that can develop as a result of liver diseases, including biliary cirrhosis, particularly in patients with cystic fibrosis. This condition is significant enough that it may prompt the consideration of liver transplantation for affected individuals.\",2\r\n1780,ENZIMAS PANCREÁTICAS,\"Enzimas pancreáticas, or pancreatic enzymes, are digestive enzymes that play a crucial role in aiding digestion, particularly for individuals with malabsorption issues. These enzymes are often supplemented in patients suffering from conditions such as EPOC (chronic obstructive pulmonary disease) and bronquiectasias, where nutrient absorption is compromised. They are especially beneficial for cystic fibrosis patients, as these individuals frequently experience difficulties in digesting fats and absorbing essential nutrients. By providing these supplements, pancreatic enzymes help improve overall nutrient absorption and support digestive health in affected patients.\",4\r\n713,ESPANA,\"Spain is a country located in Southwestern Europe, known for its organized and funded research groups in nutrition. The health law in Spain is regulated by its Constitution alongside various laws enacted by the Spanish Parliament. In the realm of medical research, Spain employs the indirect method for measuring sodium levels, particularly in patients with altered protein levels. Additionally, Spain is the site of a nutritional support study, where patients are registered for research purposes. The country also provides pancreatic enzyme preparations that are recommended for use in patients with cystic fibrosis. Furthermore, Spain has conducted studies on the prevalence of EPOC, revealing varying rates among different demographics, as well as research on diabetes incidence, which has highlighted significant health impacts.\",12\r\n1754,OSTEOPENIA,\"Osteopenia is a condition characterized by lower than normal bone density, which can lead to osteoporosis and an increased risk of fractures, particularly in patients with chronic diseases. This condition is notably more prevalent among malnourished patients with EPOC (chronic obstructive pulmonary disease) and is also commonly observed in individuals with Cystic Fibrosis.\",3\r\n1691,REFLUJO GASTROESOFÁGICO,\"Reflujo gastroesofágico, also known as gastroesophageal reflux disease (GERD), is a prevalent condition particularly noted in patients with cystic fibrosis. This condition is characterized by the backflow of stomach acid into the esophagus, which can result in symptoms such as heartburn and indigestion. In addition to these symptoms, reflujo gastroesofágico can lead to more serious complications, especially in individuals receiving enteral nutrition, where the risk of aspiration may increase. Overall, reflujo gastroesofágico is a significant health concern that requires attention due to its potential discomfort and complications.\",3\r\n1043,HARRIS-BENEDICT,\"The Harris-Benedict equation is a widely recognized formula utilized to estimate an individual's basal metabolic rate (BMR) and caloric needs, particularly in clinical settings. This equation is essential for calculating BMR, which plays a crucial role in determining the caloric requirements of patients, especially those experiencing severe trauma. Additionally, the Harris-Benedict equation is applicable in assessing the energy requirements of patients with both acute and chronic renal failure. The formula takes into account various factors, including activity level and the severity of illness, to provide a comprehensive estimation of caloric needs.\",4\r\n1688,CIRROSIS BILIAR FOCAL,\"Focal biliary cirrhosis is a liver condition that can develop in patients with cystic fibrosis, characterized by damage to the bile ducts.\",2\r\n1687,INSUFICIENCIA PANCREÁTICA EXOCRINA,\"Exocrine pancreatic insufficiency (IPE) is a condition that significantly impacts a considerable percentage of patients with cystic fibrosis. This condition hinders their ability to digest food properly, leading to challenges in nutrient absorption. As a result, individuals with cystic fibrosis who experience IPE may face difficulties in obtaining the necessary nutrients from their diet, which can affect their overall health and well-being.\",2\r\n1784,KREON 10000,\"Kreon 10000 is a pancreatic enzyme preparation available in Spain, containing 10,000 units of lipase per dose, used for patients with pancreatic insufficiency.\",2\r\n1785,KREON 25000,\"Kreon 25000 is a pancreatic enzyme preparation available in Spain, containing 25,000 units of lipase per dose, used for patients with pancreatic insufficiency.\",2\r\n1786,KREON 5000 GRANULADO,\"Kreon 5000 granulado is a pancreatic enzyme preparation available in Spain, containing 5,000 units of lipase per gram, used for patients with pancreatic insufficiency.\",2\r\n1794,AG,\"AG refers to fatty acids, which are important in dietary formulations for patients with cystic fibrosis.\",1\r\n1796,AG DE CADENA MEDIA,Medium-chain triglycerides are a type of fat that can be beneficial in the dietary management of cystic fibrosis.,1\r\n1795,AG ESENCIALES,\"Essential fatty acids are necessary fats that the body cannot produce on its own, important in dietary management for cystic fibrosis patients.\",1\r\n1788,AMILASA,Amylase is an enzyme that aids in the digestion of carbohydrates and is important for patients with pancreatic insufficiency.,1\r\n1791,ENZIMAS,,1\r\n1692,SÍNDROME DE OBSTRUCCIÓN INTESTINAL DISTAL,Distal intestinal obstruction syndrome (DIOS) is a complication in cystic fibrosis characterized by partial bowel obstruction due to thickened intestinal contents.,1\r\n1787,LIPASA,Lipase is an enzyme that helps in the digestion of fats and is crucial for patients with pancreatic insufficiency.,1\r\n1789,PROTEASA,Protease is an enzyme that helps in the digestion of proteins and is essential for patients with pancreatic insufficiency.,1\r\n1790,PACIENTES CON PANCREATITIS CRÓNICA,Patients with chronic pancreatitis often require enzyme supplementation to aid in digestion and absorption of nutrients.,1\r\n1793,TURK D ET AL.,Turk D et al. is a reference to a group of researchers or authors who have contributed to the guidelines on nutritional support in cystic fibrosis.,1\r\n714,SECCAID,SECCAID is a study that assessed the direct costs of diabetes in Spain.,1\r\n2117,INSTITUTO NACIONAL DE ESTADÍSTICA,The National Institute of Statistics in Spain concluded that stroke is a leading cause of death in the Spanish population.,1\r\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,rank\r\n90,NUTRICIÓN ENTERAL,FIBROSIS QUÍSTICA,\"NUTRICIÓN ENTERAL plays a vital role in providing nutritional support for patients with FIBROSIS QUÍSTICA. This form of nutrition is essential for effectively managing the dietary needs of individuals suffering from cystic fibrosis, as it helps to ensure they receive adequate nutrients to support their health and well-being.\",260\r\n636,NUTRICIÓN PARENTERAL,HIPERTENSIÓN PORTAL,\"Portal hypertension can arise as a complication in patients on parenteral nutrition, influencing treatment decisions\",252\r\n91,NUTRICIÓN ENTERAL,ENZIMAS PANCREÁTICAS,Pancreatic enzymes should be administered before and after enteral nutrition to aid digestion,220\r\n2525,FIBROSIS QUÍSTICA,PACIENTES,\"Cystic fibrosis, known as \"\"fibrosis quística,\"\" is a genetic disorder that affects patients, leading to a range of health complications. Individuals diagnosed with cystic fibrosis experience significant nutritional challenges as a result of their condition. To address these challenges, patients require specific dietary and nutritional interventions tailored to their needs. These interventions are crucial for managing their health and improving their quality of life.\",174\r\n2518,FIBROSIS QUÍSTICA,EPOC,\"Fibrosis Quística (Cystic Fibrosis) and EPOC (Chronic Obstructive Pulmonary Disease) are both chronic lung diseases that significantly impact respiratory health. These conditions can lead to serious health challenges, including nutritional deficiencies and osteoporosis. Fibrosis Quística can result in respiratory complications that overlap with the symptoms of EPOC, further affecting lung function and overall pulmonary health in patients. Both diseases are often discussed in the context of lung health due to their shared characteristics and the complications they can cause.\",122\r\n837,NUTRICIÓN,ESPANA,\"Nutrition research is conducted in Spain, where various organizations and researchers are dedicated to the field\",105\r\n2553,FIBROSIS QUÍSTICA,NUTRICIÓN ARTIFICIAL DOMICILIARIA,Patients with cystic fibrosis often need home nutritional treatment to address malnutrition.,101\r\n2197,ESPANA,EPOC,\"EPOC is a significant health issue in Spain, affecting a large portion of the population\",90\r\n3624,EPOC,ENZIMAS PANCREÁTICAS,\"Enzimas pancreáticas may be necessary for patients with EPOC who experience malabsorption, indicating a link between digestive health and respiratory conditions.\",82\r\n2537,FIBROSIS QUÍSTICA,NIÑOS,Children with cystic fibrosis may have specific dietary needs and require sodium supplementation,81\r\n3612,EPOC,OSTEOPENIA,Malnourished EPOC patients are at a higher risk of developing osteopenia,81\r\n1610,CALCIO,FIBROSIS QUÍSTICA,Cystic fibrosis patients may require specific nutritional support including calcium,73\r\n745,DESNUTRICIÓN,FIBROSIS QUÍSTICA,\"Cystic Fibrosis is often associated with malnutrition due to the body's inability to absorb nutrients properly, leading to a deterioration in nutritional status.\",69\r\n924,NUTRICIÓN ARTIFICIAL,ESPANA,\"In Spain, the indirect method for measuring sodium levels is commonly used in patients receiving artificial nutrition.\",66\r\n2185,DIABETES MELLITUS,FIBROSIS QUÍSTICA,\"Cystic Fibrosis can co-occur with Diabetes Mellitus, complicating nutritional management\",65\r\n1441,VITAMINA D,FIBROSIS QUÍSTICA,Vitamin D supplementation is recommended for patients with Fibrosis Quística to prevent osteoporosis,63\r\n1998,OSTEOPOROSIS,FIBROSIS QUÍSTICA,Patients with Fibrosis Quística are at risk for developing osteoporosis due to malnutrition and other health factors,62\r\n2527,FIBROSIS QUÍSTICA,ENFERMEDAD PULMONAR OBSTRUCTIVA CRÓNICA,Both conditions are chronic respiratory diseases that can lead to nutritional deficiencies,58\r\n3642,REFLUJO GASTROESOFÁGICO,NUTRICIÓN EN ONCOLOGÍA,Reflujo gastroesofágico can complicate enteral nutrition in patients,58\r\n1642,VITAMINA A,FIBROSIS QUÍSTICA,Vitamin A may be supplemented in patients with Fibrosis Quística to support health and prevent deficiencies,56\r\n2519,FIBROSIS QUÍSTICA,ESPAÑA,\"La fibrosis quística es una condición que también se estudia en España, donde se han realizado investigaciones sobre su diagnóstico y tratamiento.\",55\r\n2529,FIBROSIS QUÍSTICA,CYSTIC FIBROSIS FOUNDATION,\"Fibrosis Quística, also known as cystic fibrosis, is a genetic disorder that affects the respiratory and digestive systems. The Cystic Fibrosis Foundation plays a crucial role in the management of this condition by providing comprehensive guidelines that include nutritional recommendations essential for individuals living with Fibrosis Quística. These guidelines are designed to help manage the symptoms and improve the quality of life for those affected by cystic fibrosis.\",55\r\n2535,FIBROSIS QUÍSTICA,SODIO,Sodium supplementation is recommended for cystic fibrosis patients to prevent sodium deficiency,55\r\n2526,FIBROSIS QUÍSTICA,MORBIMORTALIDAD,\"Morbimortality is a significant concern in cystic fibrosis, impacting the health outcomes of affected individuals\",52\r\n2533,FIBROSIS QUÍSTICA,DHA,DHA is proposed for dietary supplementation to improve clinical outcomes in cystic fibrosis patients,50\r\n2534,FIBROSIS QUÍSTICA,EPA,EPA is tested in combination with DHA for dietary management in cystic fibrosis,50\r\n447,SAL,FIBROSIS QUÍSTICA,Salt supplementation may be necessary for patients with cystic fibrosis during intense physical activity,49\r\n2548,FIBROSIS QUÍSTICA,ENZIMAS PANCREÁTICAS,Pancreatic enzymes are essential for the digestion of nutrients in patients with cystic fibrosis,48\r\n2528,FIBROSIS QUÍSTICA,BRONQUIECTASIAS,Fibrosis quística can lead to the development of bronquiectasias due to chronic lung infections,48\r\n2532,FIBROSIS QUÍSTICA,HARRIS-BENEDICT,The Harris-Benedict formula is used to estimate caloric needs for patients with cystic fibrosis,48\r\n2538,FIBROSIS QUÍSTICA,ADULTOS,Adults with cystic fibrosis may also require dietary management and sodium supplementation,48\r\n2523,FIBROSIS QUÍSTICA,REFLUJO GASTROESOFÁGICO,Gastroesophageal reflux disease is frequently observed in patients with cystic fibrosis,47\r\n2530,FIBROSIS QUÍSTICA,OSTEOPENIA,Patients with Fibrosis Quística often experience osteopenia as a result of nutritional deficiencies,47\r\n2547,FIBROSIS QUÍSTICA,OLIVEIRA G,Olveira G conducted research related to nutritional support in patients with cystic fibrosis,47\r\n2521,FIBROSIS QUÍSTICA,CIRROSIS BILIAR FOCAL,Biliary cirrhosis can develop as a liver complication in patients suffering from cystic fibrosis,46\r\n2520,FIBROSIS QUÍSTICA,INSUFICIENCIA PANCREÁTICA EXOCRINA,\"Exocrine pancreatic insufficiency is a common complication in patients with cystic fibrosis, affecting their digestion\",46\r\n2522,FIBROSIS QUÍSTICA,ESTEATOSIS HEPÁTICA,Hepatic steatosis is often associated with malnutrition in cystic fibrosis patients,46\r\n2531,FIBROSIS QUÍSTICA,VITAMINAS LIPOSOLUBLES,Supplementation with liposoluble vitamins is essential for patients with Fibrosis Quística to prevent deficiencies,46\r\n2536,FIBROSIS QUÍSTICA,ÁCIDOS GRASOS ESENCIALES,Essential fatty acids are proposed for dietary supplementation to improve inflammatory responses in cystic fibrosis,46\r\n2539,FIBROSIS QUÍSTICA,KREON 10000,Kreon 10000 is recommended for use in patients with cystic fibrosis to aid in digestion,46\r\n2540,FIBROSIS QUÍSTICA,KREON 25000,Kreon 25000 is recommended for use in patients with cystic fibrosis to aid in digestion,46\r\n2541,FIBROSIS QUÍSTICA,KREON 5000 GRANULADO,Kreon 5000 granulado is recommended for use in patients with cystic fibrosis to aid in digestion,46\r\n2550,FIBROSIS QUÍSTICA,AG,Fatty acids are important components in the dietary management of cystic fibrosis,45\r\n2552,FIBROSIS QUÍSTICA,AG DE CADENA MEDIA,Medium-chain triglycerides are recommended for dietary management in cystic fibrosis,45\r\n2551,FIBROSIS QUÍSTICA,AG ESENCIALES,Essential fatty acids are critical in the dietary formulations for cystic fibrosis patients,45\r\n2544,FIBROSIS QUÍSTICA,AMILASA,Amylase is required for the digestion of carbohydrates in patients with cystic fibrosis,45\r\n2542,FIBROSIS QUÍSTICA,ENZIMAS,Enzymes are necessary for the digestion of food in patients with cystic fibrosis,45\r\n2524,FIBROSIS QUÍSTICA,SÍNDROME DE OBSTRUCCIÓN INTESTINAL DISTAL,Distal intestinal obstruction syndrome is a common gastrointestinal complication in cystic fibrosis,45\r\n2543,FIBROSIS QUÍSTICA,LIPASA,Lipase is specifically required for the digestion of fats in patients with cystic fibrosis,45\r\n2545,FIBROSIS QUÍSTICA,PROTEASA,Protease is required for the digestion of proteins in patients with cystic fibrosis,45\r\n2546,FIBROSIS QUÍSTICA,PACIENTES CON PANCREATITIS CRÓNICA,Patients with chronic pancreatitis may have similar digestive enzyme needs as those with cystic fibrosis,45\r\n2549,FIBROSIS QUÍSTICA,TURK D ET AL.,Turk D et al. provides guidelines for nutritional support in patients with cystic fibrosis,45\r\n2310,GASTROSTOMÍA,REFLUJO GASTROESOFÁGICO,REFLUJO GASTROESOFÁGICO may necessitate GASTROSTOMÍA in severe cases to manage feeding,33\r\n30,ICTUS,ESPANA,\"Ictus is a significant health issue in Spain, particularly affecting the elderly population\",25\r\n2201,ESPANA,NADYA,\"NADYA is focused on nutritional support for patients in Spain, indicating a direct connection to the country\",23\r\n2203,ESPANA,DERECHO SANITARIO,Health law in Spain is shaped by the country's Constitution and legislative framework,19\r\n3788,OSTEOPENIA,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,Patients with chronic obstructive pulmonary disease are at increased risk for osteopenia due to factors like inactivity and nutritional deficiencies,18\r\n2193,DIABETES MELLITUS TIPO 2,ESPANA,\"The incidence of diabetes mellitus type 2 was studied in Spain, highlighting its public health impact\",16\r\n2198,ESPANA,KREON 10000,Kreon 10000 is available in Spain for patients requiring pancreatic enzyme supplementation,14\r\n2199,ESPANA,KREON 25000,Kreon 25000 is available in Spain for patients requiring pancreatic enzyme supplementation,14\r\n2200,ESPANA,KREON 5000 GRANULADO,Kreon 5000 granulado is available in Spain for patients requiring pancreatic enzyme supplementation,14\r\n2196,ESPANA,SECCAID,\"The SECCAID study assessed the economic impact of diabetes in Spain, indicating its significance in healthcare budgeting\",13\r\n2202,ESPANA,INSTITUTO NACIONAL DE ESTADÍSTICA,\"The National Institute of Statistics provides data relevant to health issues in Spain, including stroke statistics\",13\r\n2755,DOPPS,HARRIS-BENEDICT,The Harris-Benedict equation is used in clinical practice to calculate energy requirements for patients in the DOPPS study,10\r\n2599,ENERGY EXPENDITURE,HARRIS-BENEDICT,The Harris-Benedict equation is a method used to estimate energy expenditure in clinical settings,9\r\n2760,HARRIS-BENEDICT,TRAUMATISMO GRAVE,The Harris-Benedict equation is used to calculate caloric needs in patients with severe trauma,7\r\n3640,INSUFICIENCIA PANCREÁTICA EXOCRINA,ENZIMAS PANCREÁTICAS,Patients with exocrine pancreatic insufficiency require pancreatic enzymes for proper digestion,6\r\n3641,CIRROSIS BILIAR FOCAL,HIPERTENSIÓN PORTAL,Portal hypertension can occur as a result of complications from biliary cirrhosis in cystic fibrosis patients,4\r\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 2000, "n": 1}, "history": null}